This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

What Influences Patient Outcome in Obstructive Airway Disease?

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Brian J Lipworth, University of Dundee
ClinicalTrials.gov Identifier:
NCT01221480
First received: October 14, 2010
Last updated: November 30, 2016
Last verified: November 2016
October 14, 2010
November 30, 2016
August 2010
October 2010   (Final data collection date for primary outcome measure)
All-cause Mortality
Same as current
Complete list of historical versions of study NCT01221480 on ClinicalTrials.gov Archive Site
  • Hospital Admissions
  • COPD exacerbations
Same as current
Not Provided
Not Provided
 
What Influences Patient Outcome in Obstructive Airway Disease?
Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.
The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample
COPD patients within NHS Tayside, UK
COPD
Not Provided
  • Beta Blocker Use
  • No beta blocker use
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
5977
October 2010
October 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Data collected through TARDIS database

Exclusion Criteria:

  • History of asthma or malignancy. Less than 50 years of age
Sexes Eligible for Study: All
50 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01221480
SHO002
No
Not Provided
Not Provided
Brian J Lipworth, University of Dundee
University of Dundee
Not Provided
Not Provided
University of Dundee
November 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP